Microsaic Systems Share Discussion Threads

[daveboy19] 17/5/2023 16:00

Safely lured yonks ago - not content, they want more.

[owenski] 17/5/2023 14:39

I wouldn't touch anything with Brandon involved and post 1101 smells like a manager posting as a PI to lure in numpties whilst everyone else is dumping.

Bargepole.

[onehanded] 17/5/2023 13:56

looks like GB trying to offload all his shares with TP as well. Maybe they will bid for DVRG LOL. Expect any holders here will be selling and moving on as now 'a dead duck'

[daveboy19] 15/5/2023 16:02

I don't know much nowadays except everyone seems to be trying to pull a fast one on somebody else!!
I feared the worst when former CEO left for 'pastures new' after describing .10p as very disappointing with the tech they have.
I'm stuck in much higher after the likes of Nyboy have long since pumped and perished which goes back full circle to the first sentence.

[cocker] 15/5/2023 14:53

One post from the guy who I suspect to be the mainman himself, don't you?.

[sultan_md_uk] 15/5/2023 11:40

Firstly, the claim that "the product just isn't strong enough" is not supported by the fact that Microsaic Systems has successfully sold its instruments to several clients, including multinational corporations like Pfizer and AstraZeneca, as well as government institutions like the UK's National Health Service (NHS).

Furthermore, the ongoing partnership with Avacta Group, a UK-based biotech company, shows that there is a potential for the technology to be used in high-throughput drug discovery, which can lead to substantial growth opportunities. It is also worth noting that the contract with Avacta is ongoing, which indicates that the partnership has been successful so far.

In terms of revenue, although Microsaic Systems reported a revenue of £0.4 million in 2021, it is important to consider the fact that the company has only recently started commercializing its products. Additionally, partnerships with major players in the industry can lead to significant revenue growth in the future.

Regarding the claim that the company should delist and become a small service company, it is worth noting that the company has been actively expanding its product portfolio. For example, in 2021, Microsaic Systems announced the launch of its second product line, the 4500 MiD, which is a more advanced version of its previous product. This indicates that the company is still investing in product development and is not solely focused on becoming a service company.

In terms of the claim that Microsaic's technology is not game-changing, it is important to note that the company's instruments offer advantages such as portability and speed, which are not found in traditional LC/MS systems. These advantages make the technology appealing to a variety of clients, particularly those in the pharmaceutical and biotech industries.

Overall, while there are challenges facing Microsaic Systems, such as competition from established players in the industry, there is evidence to suggest that the company has the potential for growth and success in the future. .................................................................................... Also just collected facts: DeepVerge plc: Microsaic has a collaboration agreement with DeepVerge, a company specializing in AI-powered microbial detection and diagnostics. Under the agreement, Microsaic's mass spectrometry technology is integrated with DeepVerge's AI platform to develop a solution for rapid detection and identification of microbial contamination. The collaboration was announced in 2020 and continues as of 2021.

Unimicro Technologies Inc.: In 2018, Microsaic signed an agreement with Unimicro Technologies Inc., a Chinese distributor of scientific equipment. Under the agreement, Unimicro became Microsaic's exclusive distributor for the MiD product line in China, Hong Kong, and Taiwan. The agreement has a three-year term with an option to extend for a further two years.

Avacta Group plc: In 2019, Microsaic signed an agreement with Avacta Group plc, a UK-based biotech company. Under the agreement, Microsaic's mass spectrometry technology is integrated with Avacta's Affimer reagents to develop a high-throughput screening platform for drug discovery. The collaboration is ongoing as of 2021.

Process Instruments & Components, Inc.: In 2021, Microsaic announced a distribution agreement with Process Instruments & Components, Inc., a US-based distributor of scientific equipment. Under the agreement, Process Instruments & Components became Microsaic's exclusive distributor for the MiD product line in the United States. The agreement has an initial term of two years.

Waters Corporation: In 2016, Microsaic signed a collaboration agreement with Waters Corporation, a US-based manufacturer of analytical instruments. Under the agreement, Microsaic's technology was integrated with Waters' mass spectrometry systems to provide a high-throughput solution for drug discovery. The collaboration ended in 2019.

Green Energy Technology Inc.: In 2016, Microsaic signed a distribution agreement with Green Energy Technology Inc., a Taiwanese distributor of scientific equipment. Under the agreement, Green Energy became Microsaic's exclusive distributor for the MiD product line in Taiwan. The agreement ended in 2018.

[cocker] 15/5/2023 11:11

New date as auditors trying to make head nor tail of deceit?

[pwal] 15/5/2023 08:20

New date. End of June.

[pwal] 28/4/2023 09:14

I'm thinking end of May.

[pwal] 28/4/2023 08:12

Anyone know the reporting date?

[dr biotech] 26/4/2023 10:37

Its been a long time since I posted on here. This company was never going to succeed, the product just isn't strong enough. I felt that at the time and whilst was always an outside chance they could license it to a major player its never happened. I think the share price was about 2p when I posted so this joins the 99% club. I've had plenty of failures similar to that and its not nice.

Looking forward it could become a small service company - but they are going to need to slim down and I'd even say delist as the time/cost of a listing may become more trouble than its worth. Good luck to those that retain the faith.








Dr Biotech - 04 Sep 2018 - 10:32:02 - 669 of 1096 Microsaic Systems - 2018 - MSYS
I wouldn't touch these.

Their single quad MS is interesting tech, but not game changing. It doesn't offer the resolution of a benchtop - it can't match a triple Quad for flexibility (or the capability for MS/MS) and it doesn't have the mass range of a ToF which is often better for large biomolecules.

I've been to a lot of production facilities in the UK and they all have full LC/MS systems to hand. A new LCMS costs around £150k (you can pick up a decent used system for about 30-40k. They are moderately complex and need someone who knows what they are doing, but once set up they can run samples every few minutes (uplc). I don't know of any manufacturers with off site facilities (admittedly as I work with the labs I wouldn't go to a site without a lab).

I know the people at Omicron in the UK. They are a small distributor with a handful of employees. I see them regularly enough and will ask them if they have had any traction with their customers.

Looking at the results I wonder if they will ever sell enough to cover their expenses. I'm not sure they will ever turn in a profit.

I hope I am wrong - the UK has a strong history in MS and it would be nice to see them succeed, but I won't be putting my money on it.

[fanon7] 23/4/2023 15:29

- Cash of £0.8M, plus accurals of £0.5M, total £1.3M
- 'Slow start to year',
- Burn rate about £150k pm.
- Pipeline (not order book) of £2M,
- Auditors looking at debt and 'disclosures' (May write off the DRVG £1.4M as bad debt),
- DVRG has £1M cash (insolvent),

[pwal] 20/4/2023 12:41

Results end of May?Positive news I hope.

[pwal] 19/4/2023 14:29

So there's a payment schedule from DVRG for money owed.

[owenski] 18/4/2023 14:31

Brandon has fingers in a lot of pies, is he not connected with that other dog of a business - PTY

Just confirms that DVRG has got no money, punters got conned with that garbage but enough warnings were given out by a handful of wiser folks.

[onehanded] 18/4/2023 14:20

The last paragraph of today's RNS tells the story of what will happen 'The phasing and quantities of receipts from DeepVerge in relation to this historic commercial debt will be subject to further discussion with the Company's auditors, and appropriate disclosures will be included within the FY22 Results.'

In other words all the rest above in today's RNS is mainly rubbish in figures and when examined after GB has left (asked to leave) the auditors will find out in fact it is 45% - 50% lower than the figures release today and in fact the company has very little money coming in and revenue. Another scandal to follow GB when he leaves as shown in DVRG when he left and his auditors examined the books and found 45% to 50% over inflated figures. Con man and doing it again. FCA need to put a stop on this manipulation of figures to enhance the CEO profits.

[onehanded] 18/4/2023 13:27

yes more lies on the RNS and trying to gloss it up and trying to push share price up before GB and his wife dump all their shares expected to be around 250 - 300 million in total before he is forced to leave when the FCA start to investigate. How he is still acting CEO after his apparent fraud at DVRG is anyone's guess, but that's the market we live in as small investors. Anyone buying now is throwing money away and as for a trade, once GB and wife start to sell the share price will half again. Clear sell and move on.

RNS says ' Although the first quarter of trading in the current year has started slowly', yes very slowly almost nothing, Will run out of money soon once GB takes all the money in pay and share options - a real disgrace to shareholders.......

[bbmsionlypostafter mk2] 18/4/2023 12:16

TW has been banging on about the fraud at DVRG & MSYS for literally years. He has held & voiced a v. low opinion of Gerry Brandon for ages, openly & repeatedly calling him a liar, a fraudster & more.





Yesterday it became apparent that Gerry Brandon had committed fraud by reporting bogus numbers for Deepverge (DVRG) before its last bailout placing. Brandon still runs Microsaic (MSYS) and you would have thought that advisers Singers and Turner Pope would have said that he had to go. How can they act for a proven fraudster? Quelle surprise, a retainer is worth more to these scholars and gentlemen than doing the right thing. But today, comes a shocking statement from Microsaic...

[darkhearse] 18/4/2023 08:26

I would sell now

[onehanded] 17/4/2023 10:45

Cash at 30 June 2022 was GBP2.56m (H1 2021: GBP4.48m) so can't be much cash left with hardly no revenue and GB getting massive pay award. Another GB CON..... investigation of GB dealing with Turner Pope is going to be interesting....

[owenski] 17/4/2023 10:01

She's probably sold a while back when they knew the game would be up, no need to RNS, that's for the little people. A con artist doesn't play by the rules. lol